HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wenqian Hu Selected Research

Complement C7 (Complement 7)

1/2022Functional genetic variants in complement component 7 confer susceptibility to gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wenqian Hu Research Topics

Disease

4Neoplasms (Cancer)
01/2022 - 01/2014
3Inflammation (Inflammations)
01/2021 - 06/2016
2Carcinogenesis
01/2021 - 12/2018
1Stomach Neoplasms (Stomach Cancer)
01/2022
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2022
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2018
1Frontotemporal Dementia (Semantic Dementia)
01/2018
1Polycythemia Vera
11/2016

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
12/2018 - 01/2018
1Complement C7 (Complement 7)IBA
01/2022
1ORALIT (ORS)IBA
01/2022
1Complement System Proteins (Complement)IBA
01/2022
1thiamine triphosphorate (TTP)IBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1Carrier Proteins (Binding Protein)IBA
01/2021
1RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2021
1TristetraprolinIBA
01/2021
1Mechanistic Target of Rapamycin Complex 1IBA
12/2018
1RNA (Ribonucleic Acid)IBA
01/2018
1DipeptidesIBA
01/2018
1Phosphotransferases (Kinase)IBA
11/2016
1EndotoxinsIBA
06/2016
1Long Noncoding RNAIBA
06/2016

Therapy/Procedure

1Therapeutics
01/2014